ASEAN Insight Provider, CrossASEAN Research

Angus Mackintosh

ASEAN Insight Provider

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<ul>
<li>The spotlight is back on <a href="https://www.smartkarma.com/entities/sea-ltd" target="_blank" data-smartkarma-citation="entities:8509:1" rel="noopener">Sea Ltd (SE US)</a> after its game <em>FreeFire </em>was named as one of 54 apps of Chinese origin to be banned in India.</li>
<li>The ban on <em>FreeFire</em> comes despite <a href="https://www.smartkarma.com/entities/sea-ltd" target="_blank" data-smartkarma-citation="entities:8509:1" rel="noopener">Sea Ltd</a>'s recent move to reduce the influence from <a href="https://www.smartkarma.com/entities/tencent-holdings-ltd" target="_blank" data-smartkarma-citation="entities:26:1" rel="noopener">Tencent</a> by scaling back its ownership of voting shares </li>
<li>We see the recent price weakness as an opportunity to accumulate <a href="https://www.smartkarma.com/entities/sea-ltd" target="_blank" data-smartkarma-citation="entities:8509:1" rel="noopener">Sea Ltd</a> given the growth story remains intact although investors may not pay the same multiple premium over peers.</li>
</ul>


The spotlight is back on Sea Ltd (SE US) after its game FreeFire was named as one of 54 apps of Chinese origin to be banned in India.
The ban on FreeFire comes despite Sea Ltd's recent move to reduce the influence from Tencent by scaling back its ownership of voting shares 
We see the recent price weakness as an opportunity to accumulate Sea Ltd given the growth story remains intact although investors may not pay the same multiple premium over peers.


Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the latest HK SFC report for aggregate short position as of Feb 4th.</li>
<li>Top short increases and decreases were tabulated for one week and four week period. </li>
<li>We highlight short interest increases in HKEx and Country Garden in the past four weeks. </li>
</ul>


We analyzed the latest HK SFC report for aggregate short position as of Feb 4th.
Top short increases and decreases were tabulated for one week and four week period. 
We highlight short interest increases in HKEx and Country Garden in the past four weeks. 


<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight weekly inflows into Kuaishou, China Mobile, Anta, CNOOC. </li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight weekly inflows into Kuaishou, China Mobile, Anta, CNOOC. 


Hong Kong Connect Flows: Kuaishou, China Mobile, Anta, CNOOC

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Equity Capital Markets

<ul>
<li>Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.</li>
<li>
<a href="https://www.smartkarma.com/entities/huitongda" target="_blank" data-smartkarma-citation="entities:33789:1" rel="noopener">Huitongda (9878 HK)</a> and <a href="https://www.smartkarma.com/entities/lepu-biopharma-co-ltd" target="_blank" data-smartkarma-citation="entities:33231:1" rel="noopener">Lepu Biopharma (LBP HK)</a> got the HK ECM market going post CNY.</li>
<li>There were no major placements this week apart from a few blocks in Korea and India.</li>
</ul>


Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Huitongda (9878 HK) and Lepu Biopharma (LBP HK) got the HK ECM market going post CNY.
There were no major placements this week apart from a few blocks in Korea and India.


ECM Weekly (13th Feb 2022) -Krafton, Huitongda, GogoX, Lepu, Adani Wilmar, Vedant, Mitsubishi Estate

Equity Analyst, LightStream Research

Shifara Samsudeen, FCMA, CGMA

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

<ul>
<li>
<a href="https://www.smartkarma.com/entities/tencent-holdings-ltd" target="_blank" data-smartkarma-citation="entities:26:1" rel="noopener">Tencent (700 HK)</a> is expected to release fourth quarter and full-year 2021 results on 23rd March 2022.</li>
<li>We expect fourth quarter 2021 earnings to be soft driven by slowdown in online advertising and online games revenues.</li>
<li>In our 3Q2021 earnings note, we highlighted that weakness in Tencent’s earnings have begun to show up and we expect further declines in 4Q2021E.</li>
</ul>



Tencent (700 HK) is expected to release fourth quarter and full-year 2021 results on 23rd March 2022.
We expect fourth quarter 2021 earnings to be soft driven by slowdown in online advertising and online games revenues.
In our 3Q2021 earnings note, we highlighted that weakness in Tencent’s earnings have begun to show up and we expect further declines in 4Q2021E.


Tencent: 4Q2021 Earnings to Soften with Decelerating Games Growth and Weak Ad Revenue

China

Tencent Holdings Limited operates as an investment holding company. The Company, through its subsidiaries, provides Internet and mobile value-added services (VAS), online advertising, and e-commerce transactions. Tencent Holdings offers services to users worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Tencent Holdings (ADR) (TCEHY US)

Sea Ltd (SE US) - A Himalayan Saga

We see the recent Sea Ltd price weakness as an opportunity to accumulate the stock, given the growth story remains intact although investors may...

Angus Mackintosh

HK Short Interest: HKEx, Country Garden

We highlight short interest increases in HKEx (388 HK) and Country Garden (2007 HK) in the past four weeks based on the latest short aggregate...

Ke Yan, CFA, FRM

Hong Kong Connect Flows: Kuaishou, China Mobile, Anta, CNOOC

We highlight Southbound connect weekly inflows into Kuaishou, China Mobile, Anta, CNOOC, as well as outflows from Tencent, Wuxi Biologics.

Ke Yan, CFA, FRM

ECM Weekly (13th Feb 2022) -Krafton, Huitongda, GogoX, Lepu, Adani Wilmar, Vedant, Mitsubishi Estate

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Sumeet Singh

Tencent: 4Q2021 Earnings to Soften with Decelerating Games Growth and Weak Ad Revenue

We expect Tencent’s 4Q2021E results to show up further weaknesses in the company’s earnings driven by decelerating growth in online games and...

Shifara Samsudeen, FCMA, CGMA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)